Search results
FTSE 100: Astrazeneca swings into profit amid double-digit revenue rise
Yahoo Finance UK· 1 year agoAstraZeneca expects ‘minimal’ sales of COVID vaccine this year. Photo: Dado Ruvic/Reuters Dado Ruvic...
AstraZeneca raises sales guidance on demand for Covid treatment
PA Media: Money via Yahoo Finance UK· 2 years agoAstraZeneca has hiked its revenue forecast for the year after strong demand for its Covid-19...
FTSE 100: AstraZeneca ups forecast as COVID treatments boost sales
Yahoo Finance UK· 2 years agoShares in the FTSE 100 drugmaker fell in early trade on Friday in London. Photo: Artur...
Covid-19 anniversary: How have GSK and Astrazeneca fared since?
CityAM via Yahoo Finance UK· 3 months agoThe Covid-19 pandemic also ignited interest in the pharmaceutical sector. Even before the UK went...
Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal
Reuters via Yahoo News· 2 years ago(Reuters) -Amgen Inc on Thursday agreed to buy ChemoCentryx Inc for $3.7 billion to gain access to a...
Immunovant (IMVT) Focus on Developing Autoimmune Disease Drug
Zacks via Yahoo News· 2 years agoImmunovant (IMVT) remains focused on developing its lead pipeline candidate, batoclimab for treating...
UPDATE 2-J&J's immune disorder drug succeeds in mid and late-stage studies
Reuters via Yahoo Finance UK· 5 months agoJohnson & Johnson's experimental drug to treat two autoimmune disorders helped relieve symptoms when tested in adult patients in mid-stage and late-stage trials, the company said on Monday.